Download presentation
Presentation is loading. Please wait.
Published byRhoda Hicks Modified over 6 years ago
1
Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez, MD, PhD The American Journal of Medicine Volume 129, Issue 7, Pages (July 2016) DOI: /j.amjmed Copyright © 2016 Elsevier Inc. Terms and Conditions
2
Figure Mechanism-based algorithm treatment for resistant hypertension. ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin II receptor blocker; MRA = mineralocorticoid receptor antagonist. The American Journal of Medicine , DOI: ( /j.amjmed ) Copyright © 2016 Elsevier Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.